Lv1
23 积分 2021-11-16 加入
ctDNA Dynamics Identifies Pseudoprogression in a Metastatic Melanoma Patient Treated With Nivolumab/Relatlimab
15小时前
已完结
Cutaneous Eruptions and Lifileucel/Interleukin 2 in Individuals With Metastatic Melanoma
2天前
已完结
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
3天前
已完结
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
3天前
已完结
Outcomes of tumor-infiltrating lymphocyte therapy in solid tumours – A systematic review and meta analysis
3天前
求助中
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII)
8天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
10天前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
22天前
已完结
Ex vivo expansion of melanoma tumor infiltrating lymphocytes leads to a dominant exhausted T cell population with lack of memory markers
22天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
22天前
已完结
皖公网安备34019202002308
